Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Perfler Bianca |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Chaida, P; Frimmel, J; Hopfer, L; Gruden, E; Perfler, B; Kailasnathan, A; Bramreiter, B; Folsselteder, J; Wurm, S; Neiss, J; Koeck, S; Wolf, D; Ratzinger, G; Tabrizi-Wizsy, NG; Glebova, K; Rinner, B; Fechter, K; Cisarova, KV; Höfler, G; Kashofer, K; Baldus, C; Stoelzel, F; Heine, A; Woelfler, A; Sill, H; Reinisch, A; Zebisch, A
RAS mutations are frequent in extramedullary AML and drive the tissue infiltration of leukemic cells via the induction of jaml
BLOOD. 2025; 146: 659-660.
Doi: 10.1182/blood-2025-659
[Oral Communication]
Web of Science
FullText
FullText_MUG
Hoeckendorf, U; Dutta, S; Kloos, A; Runtsch, M; Zoetsch, C; Wang, YJ; Perfler, B; Vosberg, S; Haferlach, T; Döhner, K; Götze, KS; Bassermann, F; Heikenwälder, M; Schmoellerl, J; Zuber, J; Wahida, A; Burk, AC; Zeiser, R; Sill, H; Jayavelu, AK; Zebisch, A; Heuser, M; Dengler, M; Jost, P
Unleashing intrinsic inflammation in AML using therapeutic cytokines overcomes pro-survival pathways and induces deep and durable remission In Vivo
BLOOD. 2025; 146: 3280-3280.
Doi: 10.1182/blood-2025-3280
[Poster]
Web of Science
FullText
FullText_MUG
Roman-Trufero, M; Blighe, K; Zebisch, A; Perfler, B; Herzog, SA; Butt, R; Auner, H; Clemo, N
Nonclinical evaluation of APL-4098, a novel GCN2 kinase inhibitor, reveals potent anti-leukemic effects through mitochondrial stress induction and synergy with venetoclax, targeting AML blasts and LSCs
BLOOD. 2025; 146: 1503-1504.
Doi: 10.1182/blood-2025-1503
[Poster]
Web of Science
FullText
FullText_MUG
Bürger, M; Amor, M; Akhmetshina, A; Bianco, V; Weichhart, T; Perfler, B; Zebisch, A; Kratky, D
Elucidating the Consequences of Loss of MMP12 in Lysosomal Acid Lipase Deficiency.
DK-MCD: 13th Scientific Retreat; SEP 26, 2023; Seggau, Austria. 2023.
[Poster]
Bürger, M; Amor, M; Akhmetshina, A; Bianco, V; Perfler, B; Zebisch, A; Kratky, D
Elucidating the Consequences of MMP12 Loss in Lysosomal Acid Lipase Deficiency
DK-MCD 12th Scientific Retreat; OCT 19, 2022; Schloss Seggau, Austria. 2022.
[Poster]
Bürger, M; Amor, M; Akmetshina, A; Bianco, V; Perfler, B; Zebisch, A; Kratky, D
Elucidating the Consequences of MMP12 Loss in Lysosomal Acid Lipase Deficiency
45th ELC Meeting ; AUG 8, 2022; Tutzing, GERMANY. 2022.
[Oral Communication]
Telebar, F; Berg, JL; Perfler, B; Bramreiter, B; Caraffini, V; Prokesch, A; Geissler, K; Penz, T; Schuster, M; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A;
Co-occurrence of mutations modifying RAS and EZH2 inactivation in chronic myelomonocytic leukemia causes amplification of RAS-AKT signaling and increases the sensitivity to AKT inhibitors
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo 15 (Suppl 3), 37–67 (2022). . 2022; 15( ):S65--OeGHO- & AHOP-Frühjahrstagung 2022; April 8-10, 2022; Graz, Austria.
[Oral Communication]
FullText
Berg, JL; Perfer, B; Hatzl, S; Reinisch, A; Pregartner, G; Klymiuk, I; Tierling, S; Geissler, G; Strobl, H; Berghold, A; Wölfer, A; Sill, H; Zebisch, A
Aberrant expression of micro-RNA-125a plays a role in the pathogenesis and treatment of chronic myelomonocytic leukemia – Update
memo - Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2021; 14: -Annual Meeting of the Austrian Society
of Haematology and Medical Oncology; APR 8-10, 2021; Wien.
[Poster]
Berg, JL; Perfler, B; Hatzl, S; Reinisch, A; Geissler, K; Strobl, H; Wölfler, A; Sill, H; Zebisch, A
Expression of miR-125a is decreased in chronic myelomonocytic leukemia and of relevance for the treatment with 5-azacytidine
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology, Magazine of European Medical Oncology. 2019; 12: 53--Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A
Increased expression of micro-RNA-23a causes resistance to cytarabine in acute myeloid leukemia.
Proceedings of the Annual Meeting of the
Austrian Society of Haematology and Medical Oncology
. 2018; Supplement 1/18: 26-26.-Annual Meeting of the Austrian Society for Hematology and Medical Oncology; APR, 19-21, 2018; Villach, AUSTRIA.
[Oral Communication]
Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, P; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wölfler, A; Sill, H; Zebisch, A
RAF kinase inhibitor protein is involved in the development of chronic myelomonocytic leukemia
memo - Magazine of European Medical Oncology. 2017; 10(2):21-21.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]